SEC, FDA boost effort to police drug claims
Federal drug and financial securities officials have stepped up their cooperation to spot drug companies that misstate their progress with regulators, the Securities and Exchange Commission's top officer in Boston said yesterday. (Full article: 542 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $9.95 1 month archives pass
- $24.95 3 months archives pass
- $74.95 1 year archives pass
